#United States #Indianapolis #Healthcare Conference #Eli Lilly #Lucas Montarce

Eli Lilly's Participation in 2025 Healthcare Conference

Eli Lilly and Company (NYSE: LLY) will actively participate in the esteemed Bank of America Securities 2025 Healthcare Conference scheduled for May 15, 2025. This event serves as a pivotal platform for healthcare leaders, and Lilly’s involvement highlights its commitment to discussing innovations and advancements in the medical field.

Lucas Montarce, who is the executive vice president and chief financial officer at Eli Lilly, will be taking part in a fireside chat at 11:40 AM Eastern Time. This engaging conversation aims to provide insights into Lilly's strategies, future directions, and the latest developments from one of the world’s leading pharmaceutical companies.

The event not only showcases Lilly’s strengths in biotechnology and pharmaceuticals but emphasizes their ongoing commitment to research and development in healthcare. Attendees can gain access to a live audio webcast of the session by visiting the “Webcasts & Presentations” section of Lilly’s investor website. For those unable to participate live, a replay of the presentation will be available for approximately 90 days following the event. This reflects Lilly’s commitment to transparency and keeping investors and stakeholders informed about its undertakings.

About Eli Lilly

Founded nearly 150 years ago, Eli Lilly and Company has been at the forefront of medical innovation, striving to bring life-changing discoveries to patients globally. With a focus on advancing health care to improve the quality of life, Lilly’s products currently support tens of millions of individuals worldwide. Their ongoing efforts encapsulate a wide array of health challenges, including diabetes management, obesity treatment, Alzheimer's disease research, and addressing various immune-related disorders, as well as some of the most challenging cancers.

At the core of Lilly's mission is the mantra of making life better for millions through innovative clinical trials that reflect the diversity of the human experience. Their commitment to ensuring that medications are both accessible and affordable is part of their broader vision to enable healthier lives for everyone, everywhere.

As the healthcare landscape continues to evolve, Lilly remains dedicated to leveraging biotechnology, chemistry, and genetic medicine to confront some of the most pressing health issues faced by societies globally. With a passionate team and robust pipeline of transformative medications, Eli Lilly is poised for significant contributions to future healthcare trends and challenges.

To learn more about Eli Lilly, their latest initiatives, and how they are redefining standards of care, visit their official website at Lilly.com and follow them on social media platforms for up-to-date information.

With the healthcare conference on the horizon, stakeholders and the public alike will be keenly watching Lilly’s presentation as it outlines their ongoing journey in transforming healthcare through science and innovation.